Skip to main content
logo
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
40.30
-1.88 (-4.46%)
At close: Nov 5, 2026, 4:00 PM EST
40.07
-0.23 (-0.57%)
After-hours: Nov 5, 2026, 7:59 PM EST

Novo Nordisk Income Statement

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
79,19578,48896,82379,14474,97676,85778,08785,68371,31168,06065,34965,86358,73154,30053,36748,09245,56641,26542,03138,333
Revenue Growth (YoY)
5.63%2.12%23.99%-7.63%5.14%12.93%19.49%30.09%21.42%25.34%22.45%36.95%28.89%31.59%26.97%25.46%27.91%24.89%24.34%19.28%
Cost of Revenue
14,17617,10013,59814,17017,90412,84612,89012,06211,30810,2749,9169,5689,7137,8568,1828,2627,2006,0696,9176,241
Gross Profit
65,01961,38883,22564,97457,07264,01165,19773,62160,00357,78655,43356,29549,01846,44445,18539,83038,36635,19635,11432,092
Selling, General & Admin
16,25616,30613,21717,14317,88018,84916,11220,27216,59216,09114,41318,62214,07515,41413,48315,09112,60911,83111,15312,822
Research & Development
15,25511,45910,28412,67115,39311,69010,3085,8129,48810,4668,6069,0928,1287,1276,7287,3255,6335,1235,2065,059
Other Operating Expenses
1,788234106-8111723-14238101-405568-309-9815-33-433-60-149-392-120
Operating Expenses
33,29927,99923,60729,73333,39030,56226,40626,32226,18126,15223,58727,40522,10522,55620,17821,98318,18216,80515,96717,761
Operating Income
31,72033,38959,61835,24123,68233,44938,79147,29933,82231,63431,84628,89026,91323,88825,00717,84720,18418,39119,14714,331
Interest Expense
-1,134-1,500--4,966--4,958--400--1,562-1,998-1,630-2,168--913-378----289
Interest & Investment Income
-1,314-4,4063075,314-613-9602,1462,1013,318--239---231
Earnings From Equity Investments
----17----17---81----189----24
Currency Exchange Gain (Loss)
--2,5543,196---1,758-1,070---76462---209-757---777-632
Other Non Operating Income (Expenses)
-443---2411,528---289562---197-366852901-2,152-1,596-451-103
EBT Excluding Unusual Items
30,14333,20362,17237,61925,51733,80537,03346,13634,38431,03231,91829,70728,06324,25424,73717,66318,03216,79517,91913,514
Merger & Restructuring Charges
-4,061--89----------------124
Gain (Loss) on Sale of Investments
---71----17---37----587---296
Asset Writedown
-4,648-6,328--3,594----10,562--5,700--2,124----760----573
Pretax Income
21,43426,87562,17234,18525,51733,80537,03335,55734,38425,33231,91827,62028,06324,25424,73716,31618,03216,79517,91913,113
Income Tax Expense
4,6945,88613,6157,2945,5117,3027,9997,3277,0835,2826,5115,6575,5854,8264,9232,7243,6273,4773,7092,221
Net Income
16,74020,98948,55726,89120,00626,50329,03428,23027,30120,05025,40721,96322,47819,42819,81413,59214,40513,31814,21010,892
Net Income to Common
16,74020,98948,55726,89120,00626,50329,03428,23027,30120,05025,40721,96322,47819,42819,81413,59214,40513,31814,21010,892
Net Income Growth (YoY)
-16.32%-20.80%67.24%-4.74%-26.72%32.19%14.28%28.53%21.46%3.20%28.23%61.59%56.04%45.88%39.44%24.79%18.86%9.86%12.57%16.89%
Shares Outstanding (Basic)
4,4054,4284,4434,4444,4464,4474,4394,4464,4524,4584,4604,4654,4774,4904,4994,5084,5234,5384,5534,568
Shares Outstanding (Diluted)
4,4234,4364,4494,4494,4474,4474,4464,4564,4614,4654,4714,4774,4894,5034,5134,5234,5374,5524,5674,581
Shares Change (YoY)
-0.54%-0.25%0.05%-0.14%-0.31%-0.42%-0.54%-0.49%-0.64%-0.83%-0.95%-1.00%-1.06%-1.09%-1.17%-1.27%-1.25%-1.31%-1.40%-1.48%
EPS (Basic)
3.804.7410.936.054.505.966.546.356.134.505.704.925.024.334.403.023.182.933.122.38
EPS (Diluted)
3.794.7310.916.044.505.966.536.346.124.495.684.915.004.324.393.013.172.933.112.38
EPS Growth (YoY)
-15.78%-20.61%67.07%-4.66%-26.47%32.74%14.96%29.15%22.40%3.94%29.39%63.07%57.73%47.44%41.16%26.47%20.30%11.41%14.13%18.81%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
28,48342,52412,773-10,81032,63827,11311,308-3,80031,73140,0335,84014435,13822,69925,1212,14021,00921,52622,066-5,066
Free Cash Flow Per Share
6.449.592.87-2.437.346.102.54-0.857.118.961.310.037.835.045.570.474.634.734.83-1.11
Dividend Per Share
-3.750-7.950-3.750-7.900-3.500-6.400-3.000-4.075-2.125-3.450
Dividend Growth (YoY)
-0%-0.63%-7.14%-23.44%-16.67%-57.05%-41.18%-18.12%-21.43%-17.95%
Gross Margin
82.10%78.21%85.96%82.10%76.12%83.29%83.49%85.92%84.14%84.90%84.83%85.47%83.46%85.53%84.67%82.82%84.20%85.29%83.54%83.72%
Operating Margin
40.05%42.54%61.57%44.53%31.59%43.52%49.68%55.20%47.43%46.48%48.73%43.86%45.82%43.99%46.86%37.11%44.30%44.57%45.55%37.39%
Profit Margin
21.14%26.74%50.15%33.98%26.68%34.48%37.18%32.95%38.28%29.46%38.88%33.35%38.27%35.78%37.13%28.26%31.61%32.27%33.81%28.41%
Free Cash Flow Margin
35.97%54.18%13.19%-13.66%43.53%35.28%14.48%-4.44%44.50%58.82%8.94%0.22%59.83%41.80%47.07%4.45%46.11%52.16%52.50%-13.22%
EBITDA
35,32036,99463,13136,65527,44237,19342,55047,87535,84233,67134,00330,34629,43826,06526,72619,17422,22520,02720,79714,600
EBITDA Margin
44.60%47.13%65.20%46.31%36.60%48.39%54.49%55.87%50.26%49.47%52.03%46.08%50.12%48.00%50.08%39.87%48.77%48.53%49.48%38.09%
D&A For EBITDA
3,6003,6053,5131,4143,7603,7443,7595762,0202,0372,1571,4562,5252,1771,7191,3272,0411,6361,650269
EBIT
31,72033,38959,61835,24123,68233,44938,79147,29933,82231,63431,84628,89026,91323,88825,00717,84720,18418,39119,14714,331
EBIT Margin
40.05%42.54%61.57%44.53%31.59%43.52%49.68%55.20%47.43%46.48%48.73%43.86%45.82%43.99%46.86%37.11%44.30%44.57%45.55%37.39%
Effective Tax Rate
21.90%21.90%21.90%21.34%21.60%21.60%21.60%20.61%20.60%20.85%20.40%20.48%19.90%19.90%19.90%16.70%20.11%20.70%20.70%16.94%
SEC Filings: 10-K · 10-Q